Record Information
Version1.0
Creation Date2016-05-22 03:43:17 UTC
Update Date2016-11-09 01:15:28 UTC
Accession NumberCHEM016771
Identification
Common NameMetaxalone
ClassSmall Molecule
DescriptionMetaxalone is a moderate to strong muscle relaxant used in the symptomatic treatment of musculoskeletal pain caused by strains, sprains, and other musculoskeletal conditions. It is marketed by King Pharmaceuticals under the brand name Skelaxin®. Its main mechanism of action is thought to involve general central nervous system depression. Metaxalone is associated with few side effects and is available as a 800 mg scored tablet.
Contaminant Sources
  • HMDB Contaminants - Urine
  • ToxCast & Tox21 Chemicals
Contaminant TypeNot Available
Chemical Structure
Thumb
Synonyms
ValueSource
SkelaxinKegg
MetassaloneHMDB
MetaxalonHMDB
MetazaloneHMDB
MetazoloneHMDB
MethaxalonumHMDB
MethoxoloneHMDB
AHR 438HMDB
Chemical FormulaC12H15NO3
Average Molecular Mass221.252 g/mol
Monoisotopic Mass221.105 g/mol
CAS Registry Number1665-48-1
IUPAC Name5-(3,5-dimethylphenoxymethyl)-1,3-oxazolidin-2-one
Traditional Namemetaxalone
SMILESCC1=CC(OCC2CNC(=O)O2)=CC(C)=C1
InChI IdentifierInChI=1S/C12H15NO3/c1-8-3-9(2)5-10(4-8)15-7-11-6-13-12(14)16-11/h3-5,11H,6-7H2,1-2H3,(H,13,14)
InChI KeyIMWZZHHPURKASS-UHFFFAOYSA-N
Chemical Taxonomy
Description belongs to the class of organic compounds known as phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring.
KingdomOrganic compounds
Super ClassBenzenoids
ClassPhenol ethers
Sub ClassNot Available
Direct ParentPhenol ethers
Alternative Parents
Substituents
  • Phenoxy compound
  • M-xylene
  • Xylene
  • Phenol ether
  • Alkyl aryl ether
  • Monocyclic benzene moiety
  • Oxazoline
  • Ether
  • Propargyl-type 1,3-dipolar organic compound
  • Organic 1,3-dipolar compound
  • Organoheterocyclic compound
  • Azacycle
  • Oxacycle
  • Organopnictogen compound
  • Hydrocarbon derivative
  • Organic oxygen compound
  • Organic nitrogen compound
  • Organonitrogen compound
  • Organooxygen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
PathwaysNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
Water Solubility1.28 g/LALOGPS
logP1.63ALOGPS
logP2.37ChemAxon
logS-2.2ALOGPS
pKa (Strongest Acidic)13.14ChemAxon
pKa (Strongest Basic)-4.9ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area47.56 ŲChemAxon
Rotatable Bond Count3ChemAxon
Refractivity59.32 m³·mol⁻¹ChemAxon
Polarizability23.74 ųChemAxon
Number of Rings2ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyView
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positivesplash10-00fr-6910000000-3d869a9d7711ed9017feSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , negativesplash10-00di-0490000000-964e6b5348bafc1182d9Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , negativesplash10-0089-0980000000-2b6e14f3b5e5c19c4e5cSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , negativesplash10-001i-0910000000-c8b21539b07eb2e7d34eSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , negativesplash10-001i-0900000000-0f09eb181838526daa7cSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , negativesplash10-001i-0900000000-018693fc5b6345ee25c5Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , negativesplash10-001i-0900000000-921f9f6e188e7466aa4dSpectrum
LC-MS/MSLC-MS/MS Spectrum - 15V, Negativesplash10-00di-0490000000-2d083d9993763dd191dbSpectrum
LC-MS/MSLC-MS/MS Spectrum - 30V, Negativesplash10-0089-0980000000-2b6e14f3b5e5c19c4e5cSpectrum
LC-MS/MSLC-MS/MS Spectrum - 90V, Negativesplash10-001i-0900000000-921f9f6e188e7466aa4dSpectrum
LC-MS/MSLC-MS/MS Spectrum - 75V, Negativesplash10-001i-0900000000-018693fc5b6345ee25c5Spectrum
LC-MS/MSLC-MS/MS Spectrum - 45V, Negativesplash10-001i-0910000000-c8b21539b07eb2e7d34eSpectrum
LC-MS/MSLC-MS/MS Spectrum - 60V, Negativesplash10-001i-0900000000-0f09eb181838526daa7cSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-08fr-4900000000-222616eabf1bcdd48049Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-08fr-6900000000-06981ad91bcbeda7d385Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-0a4i-6900000000-77e22c24cb4c6bbc81a1Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-0a4i-8900000000-54c62bf2b5c1b70898bbSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-0a4i-9700000000-82878fa5fbb78b27ef0bSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-0a4i-9500000000-66f674cba4e44834a425Spectrum
LC-MS/MSLC-MS/MS Spectrum - 90V, Positivesplash10-0a4i-9500000000-66f674cba4e44834a425Spectrum
LC-MS/MSLC-MS/MS Spectrum - 75V, Positivesplash10-0a4i-9700000000-82878fa5fbb78b27ef0bSpectrum
LC-MS/MSLC-MS/MS Spectrum - 45V, Positivesplash10-0a4i-6900000000-77e22c24cb4c6bbc81a1Spectrum
LC-MS/MSLC-MS/MS Spectrum - 60V, Positivesplash10-0a4i-8900000000-54c62bf2b5c1b70898bbSpectrum
LC-MS/MSLC-MS/MS Spectrum - 30V, Positivesplash10-08fr-6900000000-06981ad91bcbeda7d385Spectrum
LC-MS/MSLC-MS/MS Spectrum - 15V, Positivesplash10-08fr-4900000000-222616eabf1bcdd48049Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-00di-5970000000-e23b204a74eee96b313cSpectrum
Toxicity Profile
Route of ExposureNot Available
Mechanism of ToxicityNot Available
MetabolismNot Available
Toxicity ValuesNot Available
Lethal DoseNot Available
Carcinogenicity (IARC Classification)Not Available
Uses/SourcesNot Available
Minimum Risk LevelNot Available
Health EffectsNot Available
SymptomsNot Available
TreatmentNot Available
Concentrations
Not Available
DrugBank IDDB00660
HMDB IDHMDB0014798
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkMetaxalone
Chemspider ID14709
ChEBI ID711679
PubChem Compound ID15459
Kegg Compound IDC07934
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References
1. Elenbaas JK: Centrally acting oral skeletal muscle relaxants. Am J Hosp Pharm. 1980 Oct;37(10):1313-23.
2. See S, Ginzburg R: Choosing a skeletal muscle relaxant. Am Fam Physician. 2008 Aug 1;78(3):365-70.